Myocytes versus endothelial damageDINI, Frank L; ORSINI, Enrico; MARZILLI, Mario et al.Heart and metabolism. 2012, Num 54, pp 33-36, issn 1566-0338, 4 p.Article

Cardioprotective growth factorsHAUSENLOY, Derek J; YELLON, Derek M.Cardiovascular research. 2009, Vol 83, Num 2, pp 179-194, issn 0008-6363, 16 p.Article

Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injurySTRANDE, Jennifer L; WIDLANSKY, Michael E; TSOPANOGLOU, Nikos E et al.Cardiovascular research. 2009, Vol 83, Num 2, pp 325-334, issn 0008-6363, 10 p.Article

Necrostatin : A potentially novel cardioprotective agent?SMITH, Christopher C. T; DAVIDSON, Sean M; LIM, Shiang Y et al.Cardiovascular drugs and therapy. 2007, Vol 21, Num 4, pp 227-233, issn 0920-3206, 7 p.Article

Therapeutic Effects of Guggul and Its Constituent Guggulsterone : Cardiovascular BenefitsRUITANG DENG.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 4, pp 375-390, issn 0897-5957, 16 p.Article

Cardioprotective SUR2A promotes stem cell properties of cardiomyocytesLAND, Stephen C; WALKER, David J; QINGYOU DU et al.International journal of cardiology. 2013, Vol 168, Num 5, pp 5090-5092, issn 0167-5273, 3 p.Article

Metabolic cardiac protectionGUARINI, Giacinta.Heart and metabolism. 2012, Num 54, pp 25-28, issn 1566-0338, 4 p.Article

Adenosine-mediated cardioprotection in the aging myocardiumWILLEMS, Laura; ASHTON, Kevin J; HEADRICK, John P et al.Cardiovascular research. 2005, Vol 66, Num 2, pp 245-255, issn 0008-6363, 11 p.Article

Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendanPAPP, Zoltán; EDES, Istvan; MORELLI, Andrea et al.International journal of cardiology. 2012, Vol 159, Num 2, pp 82-87, issn 0167-5273, 6 p.Article

IB-MECA and cardioprotectionZHELONG XU; YEONGHO JANG; MUELLER, Robert A et al.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 3-4, pp 227-238, issn 0897-5957, 12 p.Article

Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathwayGURUSAMY, Narasimman; LEKLI, Istvan; MUKHERJEE, Subhendu et al.Cardiovascular research. 2010, Vol 86, Num 1, pp 103-112, issn 0008-6363, 10 p.Article

Connexin 43 signalling and cardioprotectionBOENGLER, K; SCHULZ, R; HEUSCH, G et al.Heart (London 1996). 2006, Vol 92, Num 12, pp 1724-1727, issn 1355-6037, 4 p.Article

Autophagy in health and disease. 5. Mitophagy as a way of lifeGOTTLIEB, Roberta A; CARREIRA, Raquel S.American journal of physiology. Cell physiology. 2010, Vol 68, Num 2, issn 0363-6143, C203-C210Article

Pharmacological cardiac protectionORSINI, Enrico; MARZILLI, Mario; MORRONE, Doralisa et al.Heart and metabolism. 2012, Num 54, pp 9-14, issn 1566-0338, 6 p.Article

FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisationBRENNAN, Jonathan P; BERRY, Roger G; BAGHAI, Max et al.Cardiovascular research. 2006, Vol 72, Num 2, pp 322-330, issn 0008-6363, 9 p.Article

Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategiesCOHEN, Michael V; YANG, Xi-Ming; DOWNEY, James M et al.Cardiovascular research. 2006, Vol 70, Num 2, pp 231-239, issn 0008-6363, 9 p.Article

New concepts in reactive oxygen species and cardiovascular reperfusion physiologyBECKER, Lance B.Cardiovascular research. 2004, Vol 61, Num 3, pp 461-470, issn 0008-6363, 10 p.Article

Frequent biomarker analysis in the isolated perfused heart reveals two distinct phases of reperfusion injuryPOVLSEN, Jonas Agerlund; LØFGREN, Bo; DALGAS, Christian et al.International journal of cardiology. 2014, Vol 171, Num 1, pp 9-14, issn 0167-5273, 6 p.Article

Re-assessing the mechanism of action of n-3 PUFAsMOLLACE, Vincenzo; GLIOZZI, Micaela; CARRESI, Cristina et al.International journal of cardiology. 2013, Vol 170, Num 2, issn 0167-5273, S8-S11, SUP1Conference Paper

Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenationLJUBKOVIC, Marko; MIO, Yasushi; MARINOVIC, Jasna et al.American journal of physiology. Cell physiology. 2007, Vol 61, Num 5, issn 0363-6143, C1583-C1590Article

Arginase inhibition mediates cardioprotection during ischaemia-reperfusionJUNG, Christian; GONON, Adrian T; SJÖQUIST, Per-Ove et al.Cardiovascular research. 2010, Vol 85, Num 1, pp 147-154, issn 0008-6363, 8 p.Article

Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusionSCHMIDT, Katharina; TISSIER, Renaud; GHALEH, Bijan et al.European heart journal. 2010, Vol 31, Num 13, pp 1655-1662, issn 0195-668X, 8 p.Article

The winding road to cardioprotectionWILLIAMS, Rupert; MARBER, Michael.Heart and metabolism. 2010, Num 46, pp 25-33, issn 1566-0338, 9 p.Article

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionPOLLIN, Toni I; DAMCOTT, Coleen M; MITCHELL, Braxton D et al.Science (Washington, D.C.). 2008, Vol 322, Num 5908, pp 1702-1705, issn 0036-8075, 4 p.Article

Inhalational Anaesthetics and CardioprotectionWEBER, N. C; SCHLACK, W.Handbook of experimental pharmacology. 2008, Vol 182, pp 187-207, issn 0171-2004, 21 p.Article